Diaphragmatic Breathing Exercises in Total Knee Arthroplasty Patients
Study Details
Study Description
Brief Summary
Rationale: While total knee replacements (TKA) are one of the most commonly performed surgical procedures in the United States, this procedure can also be very painful. Postoperative mobilization and rehabilitation is vital to a patient's recovery, but inadequate pain control can impede patients' progress. Diaphragmatic breathing is an additional non-pharmacological and non-invasive tool with no adverse effects that could aid in recovery. This will serve as a pilot study for a possible larger controlled trials.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Study population: Patients (participants) undergoing total knee arthroplasty at Keck USC Hospital at HC3
Study methodology: Patients (participants) will be taught with the aide of a handout and instructional videos preoperatively and in the recovery room on how to perform diaphragmatic breathing exercises for post-operative pain control. Patient (participant) pain levels will be assessed using the visual analog scale (VAS). The investigators will then be comparing VAS scores and daily opioid doses (morphine equivalents) between the study group and a control group. The control group will include prior patients (participants) over the past year who underwent TKA at Keck Hospital and also had pain scores and opioid usage measured, but did not receive the breathing treatment.
Study endpoints: Endpoints will include: pain levels via VAS scale, anxiety levels via VAS scale, and opioid usage (morphine equivalents).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Control Retrospective review of patients (participants) with standard analgesia post total knee arthroplasty |
|
Diaphragmatic Breathing Intervention: Participants will perform diaphragmatic breathing exercises postoperatively as part of their multi-modal pain regimen. |
Behavioral: Diaphragmatic Breathing
Simple diaphragmatic breathing exercise
|
Outcome Measures
Primary Outcome Measures
- Pain Level [Prior to intervention]
Verbal Analog Pain Score - rate pain on 0-10 scale where 0=no pain, 10= worst possible pain
- Opioid Usage (morphine equivalents) [Prior to intervention]
Opioid Usage for pain
- Anxiety Level [Prior to intervention]
Verbal Analog Score -rate anxiety on 0-10 scale where 0= no anxiety, 10= worst possible anxiety
- Pain Level [15 minutes after intervention]
Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain
- Opioid Usage (morphine equivalents) [15 minutes after intervention]
Opioid Usage for pain
- Anxiety Level [15 minutes after intervention]
Verbal Analog Score - rate anxiety on 0-10 scale where 0 =no anxiety, 10 = worst possible anxiety
- Pain Level [6 hours after intervention]
Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain
- Opioid Usage (morphine equivalents) [6 hours after intervention]
Opioid Usage for pain
- Anxiety Level [6 hours after intervention]
Verbal Analog Score- rate anxiety on 0-10 scale where 0 =no anxiety, 10 = worst possible anxiety
- Pain Level [1 day after intervention]
Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain
- Opioid Usage (morphine equivalents) [1 day after intervention]
Opioid Usage for pain
- Anxiety Level [1 day after intervention]
Verbal Analog Score - rate anxiety on 0-10 scale where 0 = no anxiety, 10 = worst possible pain
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients (participants) undergoing total knee arthroplasty with a continuous peripheral nerve block catheter
Exclusion Criteria:
-
Inability to perform or learn diaphragmatic breathing exercises or do not wish to participate in diaphragmatic breathing or study protocol
-
Pregnant patients
-
Patients without continuous peripheral nerve block catheter
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Southern California
Investigators
- Principal Investigator: Linda J Rever, MD, University of Southern California
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HS-19-00223